WHO adds weight-loss, diabetes drugs to essential medicines list | World Health Organization News

UN agency urges production of affordable generics for GLP-1 drugs to treat obesity and diabetes in developing countries.

The World Health Organization (WHO) has added a new set of drugs for obesity and diabetes to its essential medicines list, alongside treatments for cancer and cystic fibrosis.

Cheap generic versions of the glucagon-like peptide-1 (GLP-1) drugs should also be made available for people in developing countries, the United Nations agency said in…